Cellective Therapeutics
Gaithersburg
About Cellective Therapeutics
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $27.5M
- Funding stage: M&A
- Last round: Series A (Sep 2004)
- Website: cellectivetherapeutics.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/cellective-therapeutics-1979278 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.